-
EP0984692
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP0984692
| EP0984692 - NOVEL ANGIOGENESIS INHIBITORS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 16.07.2004 Database last updated on 11.01.2025 | Most recent event Tooltip | 16.07.2004 | Application deemed to be withdrawn | published on 01.09.2004 [2004/36] | Applicant(s) | For all designated states Merck & Co., Inc. 126 East Lincoln Avenue Rahway, New Jersey 07065 / US | [N/P] |
| Former [2000/11] | For all designated states MERCK & CO., INC. 126 East Lincoln Avenue Rahway, New Jersey 07065 / US | Inventor(s) | 01 /
BILODEAU, Mark, T. 126 East Lincoln Avenue Rahway, NJ 07065 / US | 02 /
HUNGATE, Randall, W. 126 East Lincoln Avenue Rahway, NJ 07065 / US | 03 /
KENDALL, Richard, L. 126 East Lincoln Avenue Rahway, NJ 07065 / US | 04 /
RUTLEDGE, Ruth 126 East Lincoln Avenue Rahway, NJ 07065 / US | 05 /
THOMAS, Kenneth, A., Jr. 126 East Lincoln Avenue Rahway, NJ 07065 / US | 06 /
RUBINO, Robert 126 East Lincoln Avenue Rahway, NJ 07065 / US | 07 /
FRALEY, Mark, E. 126 East Lincoln Avenue Rahway, NJ 07065 / US | [2000/11] | Representative(s) | Horgan, James Michael Frederic, et al Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road, Harlow Essex CM20 2QR / GB | [N/P] |
| Former [2004/27] | Horgan, James Michael Frederic, et al Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road Harlow, Essex CM20 2QR / GB | ||
| Former [2000/11] | Hiscock, Ian James, et al European Patent Department, Merck & Co., Inc., Terlings Park, Eastwick Road Harlow, Essex CM20 2QR / GB | Application number, filing date | 98923719.3 | 26.05.1998 | [2000/11] | WO1998US10590 | Priority number, date | US19970048076P | 30.05.1997 Original published format: US 48076 P | GB19980000681 | 14.01.1998 Original published format: GB 9800681 | [2000/11] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9854093 | Date: | 03.12.1998 | Language: | EN | [1998/48] | Type: | A1 Application with search report | No.: | EP0984692 | Date: | 15.03.2000 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.12.1998 takes the place of the publication of the European patent application. | [2000/11] | Search report(s) | International search report - published on: | US | 03.12.1998 | (Supplementary) European search report - dispatched on: | EP | 08.01.2001 | Classification | IPC: | A01N43/54, C07D487/04, A61K31/305, // (C07D487/04, 239:00, 231:00) | [2001/08] | CPC: |
C07D487/04 (EP);
A61P17/06 (EP);
A61P27/02 (EP);
A61P29/00 (EP);
A61P35/00 (EP);
A61P37/08 (EP);
|
| Former IPC [2000/11] | A01N43/54 | Designated contracting states | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, NL, PT, SE [2000/11] | Title | German: | ANGIOGENESE-INHIBITOREN | [2000/11] | English: | NOVEL ANGIOGENESIS INHIBITORS | [2000/11] | French: | NOUVEAUX INHIBITEURS D'ANGIOGENESE | [2000/11] | Entry into regional phase | 30.12.1999 | National basic fee paid | 30.12.1999 | Search fee paid | 30.12.1999 | Designation fee(s) paid | 30.12.1999 | Examination fee paid | Examination procedure | 16.12.1998 | Request for preliminary examination filed International Preliminary Examining Authority: US | 30.12.1999 | Examination requested [2000/11] | 22.10.2002 | Despatch of a communication from the examining division (Time limit: M06) | 28.04.2003 | Reply to a communication from the examining division | 12.08.2003 | Despatch of a communication from the examining division (Time limit: M06) | 24.02.2004 | Application deemed to be withdrawn, date of legal effect [2004/36] | 30.03.2004 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2004/36] | Fees paid | Renewal fee | 31.05.2000 | Renewal fee patent year 03 | 31.05.2001 | Renewal fee patent year 04 | 31.05.2002 | Renewal fee patent year 05 | 07.05.2003 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 31.05.2004 | 07 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XP]EP0795555 (OTSUKA PHARMA CO LTD [JP]) [XP] 1 * page 17 - page 23; table 1 *; | [XP]WO9729109 (JANSSEN PHARMACEUTICA NV [BE], et al) [XP] 1 * page 14 - page 15; table 1 *; | [X] - KIRKPATRICK W E ET AL, "3-HALO-5,7-DIMETHYLPYRAZOLO U1,5-APYRIMIDINES, A NONBENZODIAZEPINOID CLASS OF ANTIANXIETY AGENTS DEVOID OF POTENTIATION OF CENTRAL NERVOUS SYSTEM DEPRESSANT EFFECTS OF ETHANOL OR BARBITURATES", JOURNAL OF MEDICINAL CHEMISTRY,US,AMERICAN CHEMICAL SOCIETY. WASHINGTON, (19770301), vol. 20, no. 3, ISSN 0022-2623, pages 386 - 393, XP000670076 [X] 1 * page 387; table 1 * DOI: http://dx.doi.org/10.1021/jm00213a014 | International search | [X]EP0594149 ; | [X]EP0531901 ; | [X]JP07309872 ; | [X]JP05125079 ; | [X]WO9218504 ; | [X]JP03204877 | [X] - HCAPLUS, (19000101), Database accession no. 1995:315545, XP002913668 & EP0594149 A 00000000 | [X] - HCAPLUS, (19000101), Database accession no. 1993:603440, XP002913669 & EP0531901 A 00000000 | [X] - HCAPLUS, (19000101), Database accession no. 1992:551008, XP002913670 | [X] - HCAPLUS, (19000101), Database accession no. 1996:181559, XP002913671 & JP07309872 A 19951128 | [X] - HCAPLUS, (19000101), Database accession no. 1993:580816, XP002913672 & JP05125079 A 19930521 | [X] - HCAPLUS, (19000101), Database accession no. 1993:213102, XP002913673 & WO9218504 A 00000000 | [X] - HCAPLUS, (19000101), Database accession no. 1992:6580, XP002913674 & JP03204877 A 19910906 |